VEGF 165 (N-Term) 抗体
-
- 抗原
- VEGF 165
-
抗原表位
- N-Term
- 适用
- 人, 小鼠, 大鼠, 斑马鱼
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- 非结合性
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- 特异性
- Reacts with VEGF165 from human, mouse, rat, Zebrafish and other species
- 纯化方法
- Purified (protein A)
- 免疫原
- Synthetic peptide derived from N terminal part of human VEGF165.
-
-
- 应用备注
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1/500 to 1/5 000 IHC1/200 to 1/2000 - 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Must be reconstituted in distilled water.
- 浓度
- 1 mg/mL
- 缓冲液
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- 有效期
- 24 months
-
- 抗原
- VEGF 165
- 别名
- VEGF165
- 背景
- Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145.
- 基因ID
- 7422
- UniProt
- P15692
-